Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

The study created a new method to test drugs that affect hormone processing in skin.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Cyproterone acetate effectively treats hirsutism and related conditions.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

Nuclear AR levels give better insight into hormone effects in skin conditions.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.